Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 29% ± 15% | |
peripheral blood | 14 studies | 29% ± 10% | |
intestine | 7 studies | 33% ± 16% | |
kidney | 6 studies | 28% ± 13% | |
bone marrow | 5 studies | 24% ± 7% | |
lymph node | 5 studies | 29% ± 7% | |
uterus | 4 studies | 33% ± 16% | |
liver | 4 studies | 30% ± 19% | |
breast | 4 studies | 22% ± 4% | |
brain | 4 studies | 25% ± 5% | |
pancreas | 3 studies | 35% ± 7% | |
placenta | 3 studies | 24% ± 10% | |
adrenal gland | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4665.91 | 1445 / 1445 | 100% | 207.40 | 183 / 183 |
ovary | 100% | 7293.17 | 180 / 180 | 100% | 455.58 | 430 / 430 |
prostate | 100% | 4932.87 | 245 / 245 | 100% | 272.93 | 501 / 502 |
uterus | 100% | 5878.39 | 170 / 170 | 100% | 277.27 | 458 / 459 |
stomach | 100% | 4990.81 | 359 / 359 | 100% | 240.09 | 285 / 286 |
intestine | 100% | 5457.80 | 966 / 966 | 100% | 259.94 | 525 / 527 |
bladder | 100% | 5542.71 | 21 / 21 | 100% | 268.09 | 502 / 504 |
skin | 100% | 7307.31 | 1809 / 1809 | 100% | 287.14 | 470 / 472 |
breast | 100% | 6291.56 | 459 / 459 | 100% | 287.06 | 1113 / 1118 |
lung | 100% | 4887.01 | 577 / 578 | 100% | 255.22 | 1151 / 1155 |
thymus | 100% | 5626.79 | 653 / 653 | 99% | 265.92 | 601 / 605 |
pancreas | 100% | 3981.86 | 327 / 328 | 99% | 194.20 | 177 / 178 |
liver | 100% | 3436.25 | 226 / 226 | 99% | 164.98 | 402 / 406 |
brain | 99% | 3398.92 | 2618 / 2642 | 100% | 298.03 | 704 / 705 |
kidney | 100% | 4559.28 | 89 / 89 | 98% | 186.83 | 884 / 901 |
adrenal gland | 100% | 7481.58 | 258 / 258 | 95% | 166.23 | 219 / 230 |
adipose | 100% | 5880.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 347.25 | 29 / 29 |
muscle | 100% | 4270.11 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5941.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 252.77 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 128.58 | 1 / 1 |
blood vessel | 100% | 4204.55 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 265.52 | 79 / 80 |
heart | 94% | 3070.74 | 812 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 4460.99 | 867 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0006281 | Biological process | DNA repair |
GO_0043488 | Biological process | regulation of mRNA stability |
GO_0006287 | Biological process | base-excision repair, gap-filling |
GO_0006308 | Biological process | DNA catabolic process |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0000723 | Biological process | telomere maintenance |
GO_0044029 | Biological process | positive regulation of gene expression via chromosomal CpG island demethylation |
GO_0006310 | Biological process | DNA recombination |
GO_0006284 | Biological process | base-excision repair |
GO_0097698 | Biological process | telomere maintenance via base-excision repair |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005840 | Cellular component | ribosome |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0016607 | Cellular component | nuclear speck |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0090580 | Molecular function | phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands |
GO_0004519 | Molecular function | endonuclease activity |
GO_0052720 | Molecular function | class II DNA-(apurinic or apyrimidinic site) endonuclease activity |
GO_0004844 | Molecular function | uracil DNA N-glycosylase activity |
GO_0003906 | Molecular function | DNA-(apurinic or apyrimidinic site) endonuclease activity |
GO_0008296 | Molecular function | 3'-5'-DNA exonuclease activity |
GO_0004523 | Molecular function | RNA-DNA hybrid ribonuclease activity |
GO_0016890 | Molecular function | site-specific endodeoxyribonuclease activity, specific for altered base |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0008408 | Molecular function | 3'-5' exonuclease activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0008311 | Molecular function | double-stranded DNA 3'-5' DNA exonuclease activity |
GO_0003691 | Molecular function | double-stranded telomeric DNA binding |
GO_0004528 | Molecular function | phosphodiesterase I activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004520 | Molecular function | DNA endonuclease activity |
GO_0003723 | Molecular function | RNA binding |
GO_0008081 | Molecular function | phosphoric diester hydrolase activity |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0140431 | Molecular function | DNA-(abasic site) binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0008309 | Molecular function | double-stranded DNA exodeoxyribonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | APEX1 |
Protein name | Apurinic/apyrimidinic endodeoxyribonuclease 1 DNA repair nuclease/redox regulator APEX1 (EC 3.1.11.2) (EC 3.1.21.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (DNA-(apurinic or apyrimidinic site) endonuclease) (REF-1) (Redox factor-1) [Cleaved into: DNA repair nuclease/redox regulator APEX1, mitochondrial] exodeoxyribonuclease III (EC 3.1.11.2) DNA-(apurinic or apyrimidinic site) endonuclease (EC 3.1.-.-) |
Synonyms | APE1 HAP1 APX hCG_40473 APE REF1 APEX |
Description | FUNCTION: Multifunctional protein that plays a central role in the cellular response to oxidative stress. The two major activities of APEX1 are DNA repair and redox regulation of transcriptional factors. Functions as an apurinic/apyrimidinic (AP) endodeoxyribonuclease in the DNA base excision repair (BER) pathway of DNA lesions induced by oxidative and alkylating agents. Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. Also incises at AP sites in the DNA strand of DNA/RNA hybrids, single-stranded DNA regions of R-loop structures, and single-stranded RNA molecules. Has 3'-5' exoribonuclease activity on mismatched deoxyribonucleotides at the 3' termini of nicked or gapped DNA molecules during short-patch BER. Possesses DNA 3' phosphodiesterase activity capable of removing lesions (such as phosphoglycolate) blocking the 3' side of DNA strand breaks. May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation. Acts as a loading factor for POLB onto non-incised AP sites in DNA and stimulates the 5'-terminal deoxyribose 5'-phosphate (dRp) excision activity of POLB. Plays a role in protection from granzyme-mediated cellular repair leading to cell death. Also involved in the DNA cleavage step of class switch recombination (CSR). On the other hand, APEX1 also exerts reversible nuclear redox activity to regulate DNA binding affinity and transcriptional activity of transcriptional factors by controlling the redox status of their DNA-binding domain, such as the FOS/JUN AP-1 complex after exposure to IR. Involved in calcium-dependent down-regulation of parathyroid hormone (PTH) expression by binding to negative calcium response elements (nCaREs). Together with HNRNPL or the dimer XRCC5/XRCC6, associates with nCaRE, acting as an activator of transcriptional repression. Stimulates the YBX1-mediated MDR1 promoter activity, when acetylated at Lys-6 and Lys-7, leading to drug resistance. Acts also as an endoribonuclease involved in the control of single-stranded RNA metabolism. Plays a role in regulating MYC mRNA turnover by preferentially cleaving in between UA and CA dinucleotides of the MYC coding region determinant (CRD). In association with NMD1, plays a role in the rRNA quality control process during cell cycle progression. Associates, together with YBX1, on the MDR1 promoter. Together with NPM1, associates with rRNA. Binds DNA and RNA. . FUNCTION: Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. . FUNCTION: Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. . FUNCTION: Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. . FUNCTION: Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. . FUNCTION: Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. . FUNCTION: Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. . FUNCTION: Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. . FUNCTION: Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. . |
Accessions | P27695 G3V3M6 G3V3C7 ENST00000557054.1 G3V574 ENST00000553681.5 G3V359 ENST00000438886.1 ENST00000216714.8 ENST00000708795.1 G3V5Q1 ENST00000555414.5 A0A0C4DGK8 Q5TZP7 ENST00000554325.1 G3V2D9 ENST00000557181.5 G3V3Y6 G3V5D9 ENST00000708794.1 ENST00000708787.1 ENST00000555839.5 G3V5M0 ENST00000557150.5 ENST00000553368.1 ENST00000557344.5 ENST00000557592.5 ENST00000398030.8 ENST00000556054.5 H7C4A8 |